Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-23 5:04 pm Purchase | 13G | Anika Therapeutics Inc. ANIK | 1,764,607 11.900% | 1,764,607 (New Position) | View | |
2024-05-30 4:31 pm Purchase | 13D | Anika Therapeutics Inc. ANIK | Caligan Partners LP | 1,435,993 9.700% | 12,500 (+0.88%) | View |
2024-04-05 12:21 pm Purchase | 13G | Anika Therapeutics Inc. ANIK | BlackRock Inc. BLK | 1,561,112 10.700% | 177,235 (+12.81%) | View |
2024-03-06 7:30 pm Purchase | 13D | Anika Therapeutics Inc. ANIK | Caligan Partners LP | 1,423,493 9.700% | 342,133 (+31.64%) | View |
2024-02-13 4:58 pm Sale | 13G | Anika Therapeutics Inc. ANIK | VANGUARD GROUP INC | 764,045 5.220% | -219,723 (-22.33%) | View |
2024-02-09 11:09 am Purchase | 13G | Anika Therapeutics Inc. ANIK | Trigran Investments Inc. | 2,139,054 14.600% | 574,513 (+36.72%) | View |
2024-02-09 09:59 am Sale | 13G | Anika Therapeutics Inc. ANIK | DIMENSIONAL FUND ADVISORS LP | 821,452 5.600% | -138,294 (-14.41%) | View |
2024-01-24 2:27 pm Sale | 13G | Anika Therapeutics Inc. ANIK | BlackRock Inc. BLK | 1,383,877 9.500% | -32,258 (-2.28%) | View |
2024-01-22 10:52 am Sale | 13G | Anika Therapeutics Inc. ANIK | STATE STREET CORP STT | 309,041 2.110% | -599,826 (-66.00%) | View |
2023-10-06 2:34 pm Sale | 13G | Anika Therapeutics Inc. ANIK | BlackRock Inc. BLK | 1,416,135 9.700% | -1,110,667 (-43.96%) | View |
2023-09-11 06:01 am Purchase | 13D | Anika Therapeutics Inc. ANIK | Caligan Partners LP | 1,081,360 7.400% | 179,274 (+19.87%) | View |
2023-08-17 08:00 am Purchase | 13D | Anika Therapeutics Inc. ANIK | Caligan Partners LP | 902,086 6.200% | 902,086 (New Position) | View |
2023-02-14 10:33 am Sale | 13G | Anika Therapeutics Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 181,943 1.250% | -805,790 (-81.58%) | View |
2023-02-10 2:42 pm Purchase | 13G | Anika Therapeutics Inc. ANIK | DIMENSIONAL FUND ADVISORS LP | 959,746 6.600% | 103,622 (+12.10%) | View |
2023-02-10 1:24 pm Purchase | 13G | Anika Therapeutics Inc. ANIK | Trigran Investments Inc. | 1,564,541 10.700% | 71,296 (+4.77%) | View |
2023-02-09 11:07 am Purchase | 13G | Anika Therapeutics Inc. ANIK | VANGUARD GROUP INC | 983,768 6.730% | 17,855 (+1.85%) | View |
2023-02-08 09:40 am Purchase | 13G | Anika Therapeutics Inc. ANIK | STATE STREET CORP STT | 908,867 6.220% | 110,299 (+13.81%) | View |
2023-01-26 08:52 am Unchanged | 13G | Anika Therapeutics Inc. ANIK | BlackRock Inc. BLK | 2,526,802 17.300% | 0 (Unchanged) | View |
2023-01-20 09:43 am Purchase | 13G | Anika Therapeutics Inc. ANIK | BlackRock Inc. BLK | 2,526,802 17.300% | 168,185 (+7.13%) | View |
2022-10-06 5:58 pm Purchase | 13G | Anika Therapeutics Inc. ANIK | Trigran Investments Inc. | 1,493,245 10.200% | 1,493,245 (New Position) | View |